Though the history of mankind, we are strongly fighting with infected diseases that are
induced by bacteria, fungi, viruses, and other pathogens. Although a variety of medicines …

Infectious diseases are the leading cause of mortality worldwide, with viruses in particular
making global impact on healthcare and socioeconomic development. In addition, the rapid …

AIDS causes increasing mortality every year. With advancements in nanomedicine, different
nanomaterials (NMs) have been applied to treat AIDS and overcome its limitations. Among …

Topical pre-exposure prophylaxis (PrEP) with antiretroviral drugs holds promise in
preventing vaginal transmission of HIV. However, significant biomedical and social issues …

Infectious diseases hold third place in the top 10 causes of death worldwide and were
responsible for more than 6.7 million deaths in 2016. Nanomedicine is a multidisciplinary …

The rise in human pandemics demands prudent approaches in antiviral material
development for disease prevention and treatment by effective protective equipment and …

The advent of combination antiretroviral therapy (cART) has transformed HIV-1 infection into
a controllable chronic disease, but these therapies are incapable of eradicating the virus to …

The therapeutic functionality of innumerable antiretroviral drugs is supposedly obscured
owing to their low metabolic stability in the gastrointestinal tract and poor solubilization …

In recent decades, the major concern of emerging and re-emerging viral diseases has
become an increasingly important area of public health concern, and it is of significance to …

Prevention plays an invaluable role in the fight against HIV/AIDS. The use of microbicides is
considered an interesting potential approach for topical pre-exposure prophylaxis of HIV …